vs
Side-by-side financial comparison of Lucid Diagnostics Inc. (LUCD) and Pineapple Financial Inc. (PAPL). Click either name above to swap in a different company.
Lucid Diagnostics Inc. is the larger business by last-quarter revenue ($1.2M vs $707.3K, roughly 1.7× Pineapple Financial Inc.). Lucid Diagnostics Inc. runs the higher net margin — -858.5% vs -2756.2%, a 1897.7% gap on every dollar of revenue. On growth, Lucid Diagnostics Inc. posted the faster year-over-year revenue change (3.3% vs -4.8%). Over the past eight quarters, Lucid Diagnostics Inc.'s revenue compounded faster (7.9% CAGR vs -2.0%).
Lucid Diagnostics Inc. is a commercial-stage medical diagnostics firm focused on non-invasive screening tests for upper gastrointestinal diseases, including early detection of esophageal cancer and pre-cancerous lesions. It mainly serves healthcare providers and clinical partners across the United States, targeting at-risk patient populations.
LUCD vs PAPL — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.2M | $707.3K |
| Net Profit | $-10.4M | $-19.5M |
| Gross Margin | — | 48.9% |
| Operating Margin | -971.0% | -2518.8% |
| Net Margin | -858.5% | -2756.2% |
| Revenue YoY | 3.3% | -4.8% |
| Net Profit YoY | 16.0% | -3174.1% |
| EPS (diluted) | $-0.10 | $-1.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $707.3K | ||
| Q4 25 | — | $721.7K | ||
| Q3 25 | $1.2M | $730.5K | ||
| Q2 25 | $1.2M | $746.9K | ||
| Q1 25 | $828.0K | $743.3K | ||
| Q4 24 | $1.2M | $766.1K | ||
| Q3 24 | $1.2M | $598.3K | ||
| Q2 24 | $976.0K | $736.4K |
| Q1 26 | — | $-19.5M | ||
| Q4 25 | — | $-6.4M | ||
| Q3 25 | $-10.4M | $-1.8M | ||
| Q2 25 | $-4.4M | $-557.7K | ||
| Q1 25 | $-26.9M | $-595.4K | ||
| Q4 24 | $-11.5M | $-656.9K | ||
| Q3 24 | $-12.4M | $-1.7M | ||
| Q2 24 | $-11.0M | $-848.6K |
| Q1 26 | — | 48.9% | ||
| Q4 25 | — | 49.6% | ||
| Q3 25 | — | 27.8% | ||
| Q2 25 | — | 67.6% | ||
| Q1 25 | — | 43.4% | ||
| Q4 24 | — | 45.9% | ||
| Q3 24 | — | 43.2% | ||
| Q2 24 | — | 44.2% |
| Q1 26 | — | -2518.8% | ||
| Q4 25 | — | -909.1% | ||
| Q3 25 | -971.0% | -131.3% | ||
| Q2 25 | -978.8% | -93.3% | ||
| Q1 25 | -1508.1% | -80.6% | ||
| Q4 24 | -1033.8% | -90.5% | ||
| Q3 24 | -997.8% | -232.8% | ||
| Q2 24 | -1146.7% | -121.7% |
| Q1 26 | — | -2756.2% | ||
| Q4 25 | — | -891.6% | ||
| Q3 25 | -858.5% | -250.3% | ||
| Q2 25 | -381.7% | -74.7% | ||
| Q1 25 | -3249.8% | -80.1% | ||
| Q4 24 | -964.2% | -85.7% | ||
| Q3 24 | -1055.5% | -283.9% | ||
| Q2 24 | -1127.6% | -115.2% |
| Q1 26 | — | $-1.21 | ||
| Q4 25 | — | $-4.79 | ||
| Q3 25 | $-0.10 | $-0.93 | ||
| Q2 25 | $-0.08 | $-0.05 | ||
| Q1 25 | $-0.52 | $-1.73 | ||
| Q4 24 | $-0.17 | $-2.60 | ||
| Q3 24 | $-0.25 | $-11.10 | ||
| Q2 24 | $-0.23 | $-0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $47.3M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $25.8M | $27.1M |
| Total Assets | $53.2M | $48.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $47.3M | — | ||
| Q2 25 | $31.1M | — | ||
| Q1 25 | $25.2M | — | ||
| Q4 24 | $22.4M | — | ||
| Q3 24 | $14.5M | — | ||
| Q2 24 | $24.9M | — |
| Q1 26 | — | $27.1M | ||
| Q4 25 | — | $-5.5M | ||
| Q3 25 | $25.8M | $906.7K | ||
| Q2 25 | $7.9M | $842.6K | ||
| Q1 25 | $-5.4M | $739.7K | ||
| Q4 24 | $5.4M | $1.3M | ||
| Q3 24 | $6.3M | $1.3M | ||
| Q2 24 | $16.0M | $2.0M |
| Q1 26 | — | $48.9M | ||
| Q4 25 | — | $10.6M | ||
| Q3 25 | $53.2M | $5.4M | ||
| Q2 25 | $38.7M | $4.7M | ||
| Q1 25 | $32.8M | $4.0M | ||
| Q4 24 | $30.7M | $4.1M | ||
| Q3 24 | $22.6M | $4.1M | ||
| Q2 24 | $34.1M | $4.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.9M | $-3.3M |
| Free Cash FlowOCF − Capex | — | $-3.3M |
| FCF MarginFCF / Revenue | — | -462.7% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $-3.3M | ||
| Q4 25 | — | $-489.7K | ||
| Q3 25 | $-10.9M | $-507.6K | ||
| Q2 25 | $-10.5M | $397.0K | ||
| Q1 25 | $-12.5M | $-172.6K | ||
| Q4 24 | $-9.9M | $-663.6K | ||
| Q3 24 | $-10.2M | $-264.7K | ||
| Q2 24 | $-11.5M | $123.0K |
| Q1 26 | — | $-3.3M | ||
| Q4 25 | — | $-491.7K | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-264.7K | ||
| Q2 24 | — | $122.7K |
| Q1 26 | — | -462.7% | ||
| Q4 25 | — | -68.1% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -44.2% | ||
| Q2 24 | — | 16.7% |
| Q1 26 | — | 0.0% | ||
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
